第十二批集采16个品种备战!超600亿市场“药王”易主,人福“12连涨”,海思科崛起

米内网
Jan 28

精彩内容神经系统药物是国采中的“常客”。米内网数据显示,2025年前三季度中国公立医疗机构终端神经系统化药销售额超过680亿元,人福霸主地位难撼,海思科涨逾60%;TOP20产品中,“药王”易主,2大注射剂“12连涨”;16个品种满足国采入围门槛,又有哪些会被纳入第12批国采。超600亿市场,人福霸主地位难撼,海思科涨超60%米内网数据显示,2022-2024年中国城市公立医院、县级公立医院、城市...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10